Cubist Pharmaceuticals, Inc. (NASDAQ:CBST)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.

Recs

0
Player Avatar bennettwb (65.24) Submitted: 5/6/2011 1:38:50 PM : Outperform Start Price: $34.73 CBST Score: +16.52

MFI + highly rated on CAPS

Featured Broker Partners


Advertisement